The manufacturer lists the following uses for<unk> : In the United States,<unk>  is approved for the treatment of duchenne muscular dystrophy in people over the age of two.
Deflazacort
Toremifene
Nedocromil
Proxicromil
Tasimelteon
Pulmocide
Plerixafor
Imipraminoxide